ORISTANO MATTHEW
Known title: DirectorCIK: 0000938257
ORISTANO MATTHEW's purchase track record
ORISTANO MATTHEW has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/2/2022 | SPOK | $107K | +2.1% | +37.3% | -6.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SPOK | ▲ Buy | Grant | 0 | $0 | 7/26/2022 | View on chart |
| SPOK | ▲ Buy | Open Market | 15,000 | $107K | 5/2/2022 | View on chart |
| SPOK | ▲ Buy | Grant | 1,712 | $17K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Spok Holdings supports hospitals on U.S. News Best Children's Hospitals list
Spok Holdings announced that its technology supports all leading hospitals named to the U.S. News & World Report 2026-2027 Best Children's Hospitals Honor Roll. This highlights the company's role in the healthcare sector by serving top-tier medical institutions. The news serves as a brand endorsement for Spok's digital health solutions within the pediatric care market.
Spok Holdings supports hospitals on U.S. News Best Children's Hospitals list. Spok Holdings announced that its technology supports all leading hospitals named to the U.S. News & World Report 2026-2027 Best Children's Hospitals Honor Roll. This highlights the company's role in the healthcare sector by serving top-tier medical institutions. The news serves as a brand endorsement for Spok's digital health solutions within the pediatric care market.